| Date | Title | Description |
| 02.04.2024 | Lumira Ventures Announces Investment in Nocion Therapeutics ... | TORONTO, ON / ACCESSWIRE / APRIL 2, 2024 / Lumira Ventures is delighted to announce its latest inves... |
| 19.03.2024 | Fusion Pharmaceuticals to be Acquired by AstraZeneca, Accele... | HAMILTON, ON and BOSTON, March 19, 2024 /PRNewswire/ — Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a... |
| 11.03.2024 | Alexza completes acquisition of Symphony Allegro after sharh... | - |
| 07.03.2024 | Lumira Ventures Celebrates Team Promotions, Emphasizes Growt... | TORONTO, ON / ACCESSWIRE / March 7, 2024 / Lumira Ventures, a life sciences investment firm dedicate... |
| 20.02.2024 | Iterion Therapeutics Announces First Patient Dosed in Phase ... | Iterion Therapeutics, an oncology-focused biopharmaceutical company developing small molecule inhibi... |
| 14.02.2024 | enGene Announces Oversubscribed $200 Million Private Placeme... | Financing included participation from new and existing investors
Pro forma cash and cash equivalents... |
| 13.02.2024 | Transposon Announces Final Results from a Phase 2 Study of i... | TPN-101 is the first PSP treatment to reduce NfL and IL-6 levels, key biomarkers of neurodegeneratio... |
| 01.02.2024 | Endogenex Receives IDE Approval to Initiate Pivotal Clinical... | A Prospective, Randomized, Multicenter Study Assessing the Safety and Efficacy of the ReCET™ System ... |
| 30.01.2024 | COUR Pharmaceuticals Secures $105 Million in Series A Financ... | CHICAGO, Jan. 30, 2024 (GLOBE NEWSWIRE) — COUR Pharmaceuticals, a clinical-stage biotechnology compa... |
| 16.01.2024 | Cyrano Therapeutics Secures $9.0 Million Series B Financing ... | Phase 2 FLAVOR clinical trial currently enrolling 150 patients to assess the safety and effectivenes... |
| 09.01.2024 | World’s First Patients Treated With Novel Edison® Histotrips... | HistoSonics, (www.histosonics.com), the manufacturer of the non-invasive Edison® Histotripsy System,... |
| 29.11.2023 | AmacaThera Closes Series A Extension to Advance Clinical Dev... | AmacaThera, a leader in the development of novel injectable, localized therapeutics based upon its A... |
| 21.11.2023 | Summer 2024 Analyst Position Open | Looking to make your mark in the world of venture capital and life sciences innovation? Lumira Ventu... |
| 02.11.2023 | Lumira Ventures Portfolio Company enGene (Nasdaq: ENGN) Debu... | CAD$191 million gross proceeds from the transaction to support the advancement of the clinical progr... |
| 17.10.2023 | Specific Biologics Announces Additional Investment and Appoi... | Specific Biologics Inc. (“Specific”), a venture-backed, early-stage genome editing company, is pleas... |
| 12.10.2023 | Life Sciences BC Announces Companies and Mentors for Fourth ... | Life Sciences BC welcomes the companies and mentors participating in its 2024 Investor Readiness Pro... |
| 12.10.2023 | Edesa Biotech to Receive Up To C$23 Million in Funding from ... | Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on inflammator... |
| 12.10.2023 | Cyrano Therapeutics Enrolls First Patient in Phase 2 Trial o... | There is currently no FDA-approved therapy for this increasingly prevalent and serious chronic senso... |
| 11.10.2023 | Endotronix Receives IDE Approval for the Market Expanding PR... | Endotronix, Inc., a digital health and medical technology company dedicated to advancing the treatme... |
| 10.10.2023 | OpSens, Inc Acquired by Haemonetics for $345 Million | Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innov... |
| 10.10.2023 | FDA Awards HistoSonics Clearance of its First-of-a-Kind Edis... | HistoSonics®, (www.histosonics.com), the manufacturer of the Edison® System and novel histotripsy th... |
| 28.09.2023 | Deka Biosciences Closes USD $20 Million Series B2 Financing ... | Sept. 28, 2023 — Maryland-based biotech company Deka Biosciences (“Deka”) today announced that it ha... |
| 07.09.2023 | enGene Appoints Richard Bryce, MBChB, MRCGP, MFPM, as Chief ... | enGene, Inc., a clinical-stage biotechnology company mainstreaming gene therapy through its novel pl... |
| 28.08.2023 | Molly Shoichet Joins PRIME as New Scientific Director for Pr... | AmacaThera Co-Founder, Chief Scientific Officer and University Professor Molly Shoichet is the new S... |
| 23.08.2023 | Fall 2023 Lumira Venture Innovation Program (VIP): Venture F... | Looking to make a career in life sciences innovation? Our Venture Innovation Program (VIP) is accept... |
| 15.08.2023 | Thryv Therapeutics announces FDA clearance for Phase 1 Study... | Montreal, Quebec – August 15, 2023 – Thryv Therapeutics Inc., a clinical stage biotechnology company... |
| 13.06.2023 | A 5-Year, $50k Pledge: Supporting Mélanie’s Way on Their Mis... | Mélanie’s Way is a Canadian charity dedicated to granting personalized ‘wishes’ to send women battli... |
| 13.06.2023 | DAMONA Pharmaceuticals Appoints John Reilly as Chief Executi... | TORONTO, June 13, 2023 — DAMONA Pharmaceuticals, a preclinical biopharmaceutical company focused on ... |
| 24.05.2023 | Managing General Partner, Peter van der Velden Wins the 2023... | Throughout his more-than-30-year career, Peter van der Velden’s focus has not only been on investing... |
| 23.05.2023 | Endotronix Extends Positive Outcomes with 12-month Data Rele... | The study met secondary study endpoints and long-term sensor use was associated with significant imp... |
| 23.05.2023 | Cadence Neuroscience Secures $26 Million in Series B Financi... | Cadence Neuroscience announced that it has secured $26 million in Series B financing. The round was ... |
| 27.04.2023 | Antiva Biosciences Closes $53 Million Series E Equity Financ... | Proceeds to Support Key Efficacy Studies for ABI-2280 including Phase 2 Trial in High-Grade Cervical... |
| 19.04.2023 | PIC Therapeutics Presents Pre-Clinical Data Update on eIF4E ... | PIC Therapeutics, Inc., a biotechnology company pioneering the discovery and development of first-in... |
| 12.04.2023 | Fusion Pharmaceuticals Announces IND Clearance For FPI-2068,... | Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing ... |
| 10.04.2023 | Biotheryx Announces Research Collaboration and License Agree... | Biotheryx, Inc., a biopharmaceutical company discovering and developing a portfolio of first-in-clas... |
| 06.04.2023 | Deka Biosciences Announces First-in-Human Dose in Phase 1 Cl... | Deka Biosciences (“Deka”), a clinical-stage biotechnology company focused on developing novel cytoki... |
| 05.04.2023 | Endotronix Announces Enrollment Completion of PROACTIVE-HF P... | Endotronix, Inc., a digital health and medical technology company dedicated to advancing the treatme... |
| 05.04.2023 | OpSens Announces 1,000th SavvyWire Procedure | OpSens Inc. (“OpSens” or the “Company”) (TSX: OPS) (OTCQX: OPSSF), a medical device cardiology-focus... |
| 05.04.2023 | HistoSonics Announces First Ever Kidney Tumor Treatment Usin... | HistoSonics, (www.histosonics.com), the developer of a non-invasive platform and novel sonic beam th... |
| 06.03.2023 | Congruence Therapeutics Announces Close of Series A Extensio... | Congruence Therapeutics, a biotechnology company working at the interface of computational and exper... |
| 28.02.2023 | Rare Disease Day 2023 | Today, February 28th, 2023, is Rare Disease Day. Celebrated internationally, the day is an opportuni... |
| 19.02.2023 | Pharmasset Initiates Phase 2a Trial with PSI-7977, a Chirall... | - |
| 08.02.2023 | 2023 Lumira Venture Innovation Program (VIP): Fellow and Sum... | Looking to make a career in life sciences innovation? Our Venture Innovation Program (VIP) is accept... |
| 26.01.2023 | XyloCor Therapeutics Reports Positive Topline Safety and Eff... | No serious adverse events related to drug product were reported
Patients demonstrated improvements i... |
| 18.01.2023 | Cyrano Therapeutics Announces FDA Clearance of IND Applicati... | Currently no FDA-approved therapy for this serious condition |
| 05.01.2023 | Cardiac Dimensions Raises $35 Million in Series D Financing | Funds Expected to Support Enrollment in U.S. Pivotal EMPOWER Trial and European Commercial Expansion... |
| 05.01.2023 | AmacaThera’s Lung Cancer Applications Recognized in QuickFir... | AmacaThera, a clinical-stage biotechnology company developing advanced injectable biomaterials for l... |
| 03.01.2023 | Deka Biosciences, Inc Announces Submission of Investigationa... | Important Regulatory Milestone Provides Runway to Move DK210 (EGFR) into the Clinical Phase |
| 03.01.2023 | FDA Grants Fast Track to Edesa Biotech’s ARDS Drug Candidate... | Fast Track improves the speed and frequency of communication with FDA, potentially leading to earlie... |
| 13.12.2022 | HistoSonics Announces $100 Million in Financings and New App... | Financings Planned to Support Rapid Expansion of Histotripsy Platform as Company Welcomes Silk Road ... |
| 24.11.2022 | World Antimicrobial Awareness Week 2022 | Antimicrobial resistance (AMR) occurs when microbes (bacteria, viruses, fungi and parasites) change ... |
| 08.11.2022 | Fusion Pharmaceuticals Appoints Dmitri Bobilev, M.D. As Chie... | Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing ... |
| 27.10.2022 | Unknown Error. | - |
| 19.10.2022 | Lumira Ventures Participates In The Closing of PIC Therapeut... | October 19, 2022 – PIC Therapeutics, Inc., a biopharmaceutical company dedicated to developing life-... |
| 10.10.2022 | World Mental Health Day 2022 | In 2021, Lumira Ventures and Angelini Pharma launched the Angelini Lumira Biosciences Fund (ALBF) to... |
| 26.09.2022 | DAMONA Pharmaceuticals Raises US$5.5 Million Seed Stage Fina... | TORONTO, Ontario, September 26, 2022 — DAMONA Pharmaceuticals today announced the closing of a seed ... |
| 13.09.2022 | A Look Around The Corner For Life Sciences: Nikhil Thatte Sp... | Tomorrow, Tuesday, September 13th, 2022 at 3 pm ET, Lumira Ventures Principal, Nikhil Thatte will be... |
| 09.09.2022 | Deka Biosciences Appoints Chief Medical Officer and Vice Pre... | GERMANTOWN, Md., Sept. 8, 2022 /PRNewswire/ — Deka Biosciences (“Deka”), a biotech company focused o... |
| 22.08.2022 | 2022 Lumira Venture Innovation Program (VIP): Fall Cohort Ap... | The Venture Innovation Program is a 6-12 month program for Ph.D., MBA, and MD students across Canada... |
| 02.08.2022 | Satsuma Pharmaceuticals Announces Completion of Enrollment i... | Satsuma Pharmaceuticals, Inc. (Nasdaq: STSA), a clinical-stage biopharmaceutical company developing ... |
| 27.07.2022 | Summer Office Hour Registration is Open! | Lumira Ventures is excited to present our 2022 Office Hours beginning this August! Every Wednesday f... |
| 26.07.2022 | X4 Pharmaceuticals Announces $55 Million Private Placement F... | X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development of novel CXCR4 ta... |
| 21.07.2022 | Nikhil Thatte, Hosts the 2022 Life Science Future – Medtech,... | Thursday, July 21st, 2022 at 1 pm ET, Lumira Ventures Principal, Nikhil Thatte hosts the Investor Re... |
| 11.07.2022 | Expanding Pipeline Leads to Name Change – LQT Therapeutics N... | LAVAL, Québec, Canada | 11 July 2022 | Thryv Therapeutics Inc. is excited to announce the evolution ... |
| 28.06.2022 | Paused | - |
| 28.06.2022 | XyloCor Therapeutics Achieves Target Enrollment in Phase 2 E... | XyloCor Therapeutics, a clinical-stage biopharmaceutical company developing novel gene therapies for... |
| 24.06.2022 | Medexus Generates Revenue of US$76.7 Million in Fiscal Year ... | Medexus Pharmaceuticals (Medexus) (TSX: MDP) (OTCQX: MEDXF) today announced its operating and financ... |
| 15.06.2022 | Lumira Ventures Builds Upon Presence in Western Canada with ... | TORONTO, Ontario, June 14, 2022 — Lumira Ventures, a global healthcare venture capital firm, announc... |
| 14.06.2022 | Corvia Medical Closed $54 Million Financing to Support Plann... | Existing investor syndicate supports atrial shunting as effective therapy for heart failure patients |
| 07.06.2022 | Lumira Ventures Announces Appointment of David Novak as Vent... | Accomplished Biotechnology Industry Equity Analyst Will Support Firm’s Public Market Investment Init... |
| 06.06.2022 | G1 Therapeutics Presents Promising Trilaciclib Data at ASCO | Data Presented at ASCO Demonstrate Trilaciclib Helps Protect Against Severe Neutropenia, Severe Anem... |
| 01.06.2022 | HistoSonics Hits Pivotal Clinical Trial Milestone In #HOPE4L... | Company Continues to Build as It Prepares for FDA Submission and Clearance of Its Breakthrough Thera... |
| 27.05.2022 | Lumira Ventures is Looking for a Controller to Join Our Team | Lumira Ventures is an impactful investor and you will share our passion for innovation and being par... |
| 26.05.2022 | Nikhil Thatte Hosts Invest Canada 2022: Investing in Life Sc... | This Thursday, May 26th, 2022, join Lumira Ventures Principal, Nikhil Thatte as he leads the Investi... |
| 24.05.2022 | HistoSonics Announces Agreement with GE Healthcare | MINNEAPOLIS, May 23, 2022 — HistoSonics Inc., developer of a completely non-invasive platform using ... |
| 18.05.2022 | XyloCor Therapeutics Presents Preliminary Clinical Data from... | Wayne, PA, May 18, 2022 — XyloCor Therapeutics, a clinical-stage biopharmaceutical company developin... |
| 11.05.2022 | Alice Luo Presents Lumira Ventures at the 2022 Life Sciences... | On Wednesday, May 11th, 2022, Lumira Ventures Analyst, Alice Luo will represent Lumira during her co... |
| 10.05.2022 | Suman Rao Serves as a Business Mentor For The McGill Inventi... | Beginning May 2, 2022 until July 13, 2022, Lumira Ventures Associate, Suman Rao will act as a busine... |
| 04.04.2022 | Nikhil Thatte Speaks at the Open for Business Ontario: Life ... | Wednesday, April 6th, 2022, Lumira Ventures Principal, Nikhil Thatte speaks on a panel of industry l... |
| 14.03.2022 | 2022 Lumira Venture Innovation Program Information (Lumira V... | The Venture Innovation Program is a 6-12 month program for Ph.D., MBA, and MD students across Canada... |
| 08.03.2022 | Celebrating The Inspirational Women of Lumira Ventures: Inte... | Every year on March 8th, we observe International Women’s Day by honoring the social, political, eco... |
| 02.03.2022 | OncoMyx Appoints Robert Williamson Chief Business and Chief ... | OncoMyx Therapeutics, a privately-held oncolytic virus immunotherapy company, today announced the ap... |
| 28.02.2022 | Rare Disease Day 2022 | Today is Rare Disease Day and we at Lumira Ventures are proud of our ongoing commitment to supportin... |
| 24.02.2022 | Peter van der Velden Talks All Things VC on the McRock Live ... | This Friday February 25th, Join Lumira Ventures Managing General Partner, Peter van der Velden for a... |
| 08.02.2022 | enGene Announces Positive Preliminary Phase 1/2 Data with EG... | enGene Inc., a clinical-stage biotechnology company pioneering novel non-viral gene therapies for lo... |
| 08.02.2022 | Congruence Therapeutics Inc. Announces US$50 million Series ... | Congruence Therapeutics, a biotechnology company working at the interface of computational and exper... |
| 03.02.2022 | Peter van der Velden is the Keynote Speaker and Panelist at ... | On Friday, February 4th, Lumira Ventures General Partner and Managing Director, Peter van der Velden... |
| 18.01.2022 | XyloCor Therapeutics Expands Leadership Team with Accomplish... | XyloCor Therapeutics, a clinical‑stage biopharmaceutical company developing novel gene therapies for... |
| 13.01.2022 | Edesa Biotech Receives Canadian Approval to Test COVID-19 Dr... | Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company focused on inflammator... |
| 11.01.2022 | LQT Therapeutics Announces Collaboration with Leading Cancer... | LQT Therapeutics, Inc. (“LQTT”) is pleased to announce a collaboration with the laboratory of Dr. Do... |
| 10.01.2022 | Fusion Pharmaceuticals Announces Nomination Of First Targete... | Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing ... |
| 06.01.2022 | Antiva Biosciences Named Winner of Global Women’s HealthTech... | Honor Recognizes Companies Advancing Innovative Solutions to Improve Women’s Health and Safety in Em... |
| 06.01.2022 | Lumira Ventures Announces Promotion of Lu Han, Ph.D. to Part... | TORONTO, January 6, 2022 – Lumira Ventures, a leading North American healthcare venture capital firm... |
| 06.01.2022 | LQT Therapeutics Announces Award by the European Joint Progr... | Closing the gap between industry and academia to place patients directly at the center of research e... |
| 05.01.2022 | Endotronix Announces FDA Approval for PROACTIVE-HF Pivotal T... | Endotronix, Inc., a digital health and medical technology company dedicated to advancing the treatme... |
| 16.12.2021 | Specific Biologics Closes Seed Financing with Industry Leade... | Specific Biologics Inc. (“Specific”) today announced that it has closed its first institutional fina... |
| 14.12.2021 | Antios Therapeutics and Arbutus Biopharma Announce First Pat... | Antios Therapeutics, Inc. (“Antios”) and Arbutus Biopharma Corporation (Nasdaq: ABUS) today announce... |
| 13.12.2021 | OpSens Announces 510(K) Submission to U.S FDA for New Guidew... | OpSens Inc. (“OpSens” or the “Company”) (TSX: OPS) (OTCQX: OPSSF), a medical device cardiology-focus... |
| 08.12.2021 | Lumira Co-Leads OncoMyx $50 Million Series B to Advance a No... | OncoMyx Therapeutics, a privately-held immuno-oncology platform company, today announced the closing... |
| 07.12.2021 | Suman Rao Speaks as an Investor Judge at the 2021 Venture Su... | Join Lumira Ventures, Associate, Suman Rao for the 2021 Venture Summit Virtual Connect. The summit b... |